TOP TIERMARKET NEWSWIRE
SEC Form 4 history

NURIX THERAPEUTICS I (NRIX) insider trades

NURIX THERAPEUTICS I (NRIX) insider trading activity (SEC Form 4). Over the trailing 90 days, NRIX insiders filed 0 purchases totalling $0 and 11 sales totalling $2.0M — net SELLING of $2.0M. Most recent filing: Aug 5, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
11
$2.0M
Net (90d)
-$2.0M
net selling
Most recent
Aug 5, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Aug 5, 2026Hansen GwennChief Scientific OfficerS SaleOE—$25.00$109Kfiling
Aug 5, 2026Hansen GwennChief Scientific OfficerS Sale—$24.36$100Kfiling
Aug 4, 2026Van Houte HansCFOS Sale—$24.36$116Kfiling
Aug 3, 2026Ring ChristineGCS SaleOE—$23.05$382Kfiling
Jul 30, 2026Van Houte HansCFOS SaleOE—$23.38$67Kfiling
Jul 30, 2026Ring ChristineGCS SaleOE—$23.38$90Kfiling
Jul 30, 2026Hansen GwennChief Scientific OfficerS SaleOE—$23.38$90Kfiling
Jul 2, 2026Ring ChristineGCS SaleOE—$23.56$259Kfiling
Jun 25, 2026Hansen GwennChief Scientific OfficerS Sale—$20.00$108Kfiling
Jun 25, 2026Ring ChristineGCS SaleOE—$20.06$581Kfiling
Jun 2, 2026Ring ChristineGCS SaleOE—$16.60$135Kfiling